Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has updated its date references, removing older dates and adding new ones for March 2025.
    Difference
    0.3%
    Check dated 2025-03-11T04:28:53.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The webpage has updated its date references to February 2025, indicating a shift in the timeline of content. Additionally, the previous notice regarding heavy traffic affecting services has been removed.
    Difference
    0.8%
    Check dated 2025-02-24T20:55:30.000Z thumbnail image
  5. Check
    33 days ago
    No Change Detected
  6. Check
    40 days ago
    Change Detected
    Summary
    The webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.5%
    Check dated 2025-02-10T09:50:25.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-03T08:30:01.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T22:31:17.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.1%
    Check dated 2025-01-12T17:57:04.000Z thumbnail image

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.